The goal of AMFm is to improve access to artemisinin-based combination therapies (ACTs), the most effective anti-malaria treatment. The AMFm pilot phase was launched in April 2009 and began operations in July 2010. It set out to increase availability, particularly through private outlets where most people seek their treatments, and drive down the price of ACTs through a factory-gate global subsidy of ACTs combined with country-level measures to support its implementation.
MalariaWorld received a request from Africa Fighting Malaria (AFM) to alert its subscribers to the recent publication of its policy paper titled: 'The Global Fund's Malaria Medicine Subsidy: A nice idea with nasty implications'...
Access to HIV and malaria control programmes for refugees and internally displaced persons (IDPs) is not only a human rights issue but a public health priority for affected populations and host populations.